- Report
- January 2025
- 100 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- September 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- September 2024
- 183 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Report
- February 2024
- 114 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- May 2022
- 42 Pages
Global
From €1917EUR$2,000USD£1,602GBP
The Duodenal Ulcer Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Duodenal Ulcer Drugs are used to treat duodenal ulcers, which are sores that form in the lining of the duodenum, the first part of the small intestine. These drugs work by reducing the amount of acid produced in the stomach, which helps to reduce pain and promote healing. Commonly prescribed drugs include proton pump inhibitors, H2 blockers, and antibiotics.
Some companies in the Duodenal Ulcer Drug market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and GlaxoSmithKline. Show Less Read more